4.6 Article

Inactivation of axon guidance molecule netrin-1 in human colorectal cancer by an epigenetic mechanism

期刊

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2022.04.069

关键词

Netrin-1; Axon guidance; Colorectal cancer; DNA methylation; VEGF-A

资金

  1. Japan Society for the Promotion of Science (JSPS) KAKENHI [18K08984, 21K09192]
  2. Chugoku Occupational Health Association
  3. Intramural Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health
  4. Ehime University Proteo-Science Center (PROS) and Advanced Research Support Center

向作者/读者索取更多资源

Netrin-1 expression is significantly reduced in colorectal cancer tissues compared to normal tissues, and DNA methylation plays a role in the repression of NTN1 transcription in CRC. NTN1 DNA hypermethylation is associated with advanced CRC disease.
Netrin-1, the protein product of the NTN1 gene, is an axon guidance molecule implicated in regulation of cell survival and tumorigenesis. Expression of the netrin-1 receptors deleted in colorectal cancer (DCC) and uncoordinated 5 homolog (UNC5H) is frequently silenced in colorectal cancer (CRC) by either loss of heterozygosity or epigenetic mechanisms. However, netrin-1 expression and regulation in CRC are mostly unknown. Here, we report that NTN1 expression is significantly reduced in most CRC tissues compared to the adjacent normal intestinal mucosa, and that NTN1 DNA methylation is significantly higher in CRCs (24.6%) than in the adjacent normal intestinal mucosa (4.0%). In 6 CRC cell lines, NTN1 expression is low. Treatment with 5-Aza-20-deoxycytidine increased expression of NTN1 in CRC cell lines, indicating that DNA methylation represses NTN1 transcription in CRCs. NTN1 DNA hypermethylation was significantly associated with advanced CRC disease. Median netrin-1 serum levels were significantly decreased in CRC patients (330.1 pg/mL) compared with normal individuals (438.6 pg/mL). Our results suggest that netrin-1 is a candidate biomarker for CRC. (C) 2022 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据